Bone Marrow Niches for Hematopoietic Stem Cells and Immune Cells

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|11|3|201-206

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.11, Iss.3, 2012-06, pp. : 201-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cells today: B1. Bone marrow stem cells

By Edwards RG  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 541-583

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Integral Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells

By  

Current Drug Targets, Vol. 6, Iss. 1, 2005-02 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory Cross Talks of Bone Cells, Hematopoietic Stem Cells and the Nervous System Maintain Hematopoiesis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 3, 2012-06 ,pp. : 170-180

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targeting Regulation of Proliferation and Differentiation of the Bone Marrow-Derived Mesenchymal Stem Cells or Mesenchymal Stromal Cells

By  

Current Drug Targets, Vol. 13, Iss. 4, 2012-04 ,pp. : 561-571

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell Therapy for Arterial Restenosis: Potential Parameters Contributing to the Success of Bone Marrow-Derived Mesenchymal Stromal Cells

By Forte Amalia   Rinaldi Barbara   Sodano Loredana   Berrino Liberato   Rossi Francesco   Finicelli Mauro   Grossi Mario   Cobellis Gilda   Botti Chiara   Feo Marisa   Santè Pasquale   Galderisi Umberto   Cipollaro Marilena  

Cardiovascular Drugs and Therapy, Vol. 26, Iss. 1, 2012-02 ,pp. : 9-21

Springer Publishing Company

Access to resources Recommend Favorite